# MIRT and Rotigotine in the Early Stage of PD

> **NCT02100176** · — · UNKNOWN · sponsor: **Ospedale Generale Di Zona Moriggia-Pelascini** · enrollment: 40 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **OTHER:** Multidisciplinary intensive rehabilitation treatment
- **DRUG:** Rotigotine

## Key facts

- **NCT ID:** NCT02100176
- **Lead sponsor:** Ospedale Generale Di Zona Moriggia-Pelascini
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2014-03
- **Final completion:** 2014-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02100176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02100176, "MIRT and Rotigotine in the Early Stage of PD". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02100176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*